Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Urovant Sciences Ltd (UROV)

Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Sumitovant Biopharma Completes Acquisition of Urovant Sciences Globe NewsWire - Mon Mar 29, 2021

NEW YORK, LONDON, IRVINE, CA & BASEL, SWITZERLAND, March 29, 2021 (GLOBE NEWSWIRE) -- Sumitovant Biopharma and Urovant Sciences (formerly Nasdaq: UROV) jointly announced today the completion of the merger...

UROV : 16.24 (+0.06%)
Hercules Capital Reports Fourth Quarter and Full-Year 2020 Financial Results Business Wire - Tue Feb 23, 2021

Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by...

DASH : 172.16 (-0.02%)
MASS : 2.53 (-1.17%)
ACEV : 9.78 (+7.00%)
ASPL : 9.93 (+0.30%)
ACTC : 18.09 (-4.84%)
PACE : 11.20 (+0.36%)
UBER : 70.03 (+0.62%)
UROV : 16.24 (+0.06%)
NEOS : 1.1500 (-2.54%)
AYTU : 1.5100 (+1.34%)
HTGC : 18.77 (-0.27%)
HCXZ : 25.20 (unch)
Urovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 Results Business Wire - Fri Feb 12, 2021

Urovant Sciences (Nasdaq: UROV) today reported financial results for its fiscal quarter ended December 31, 2020.

UROV : 16.24 (+0.06%)
Urovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the Data and Safety Monitoring Board Business Wire - Thu Feb 11, 2021

Urovant Sciences (Nasdaq: UROV) announced today that the independent Data and Safety Monitoring Board (DSMB) has recommended the continuation of the phase 2a study of URO-902, a novel gene therapy product,...

UROV : 16.24 (+0.06%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates MDCA, NHLD, COHR, UROV; Shareholders Are Encouraged to Contact the Firm Globe NewsWire - Thu Feb 4, 2021

NEW YORK, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

MDCA : 5.42 (-3.39%)
NHLD : 3.25 (unch)
COHR : 107.55 (+4.03%)
UROV : 16.24 (+0.06%)
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates UROV, WTRE, CBMG, NAV; Shareholders Are Encouraged to Contact the Firm Globe NewsWire - Mon Jan 25, 2021

NEW YORK, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

UROV : 16.24 (+0.06%)
WTRE : 18.32 (-0.06%)
CBMG : 19.75 (unch)
NAV : 44.50 (+0.16%)
ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROV Globe NewsWire - Sat Jan 16, 2021

NEW YORK, Jan. 16, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

CBMG : 19.75 (unch)
CGIX : 4.61 (-2.33%)
UROV : 16.24 (+0.06%)
MERGER INVESTIGATION: Halper Sadeh LLP Investigates CBMG, ALSK, UROV, NAV; Shareholders Are Encouraged to Contact the Firm Globe NewsWire - Fri Jan 8, 2021

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CBMG : 19.75 (unch)
ALSK : 3.40 (+0.29%)
UROV : 16.24 (+0.06%)
NAV : 44.50 (+0.16%)
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, WORK, and UROV AccessWire - Sun Jan 3, 2021

NEW YORK, NY / ACCESSWIRE / January 3, 2021 / Lifshitz Law Firm, P.C.: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties...

CBMG : 19.75 (unch)
CBLI : 3.17 (-7.31%)
WORK : 45.20 (+0.09%)
UROV : 16.24 (+0.06%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – UROV, EIGI, SNCA, CLCT Globe NewsWire - Wed Dec 30, 2020

NEW YORK, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

UROV : 16.24 (+0.06%)
EIGI : 9.49 (unch)
SNCA : 9.9600 (-1.19%)
CLCT : 91.92 (+0.04%)

Barchart Exclusives

Should You Buy This Nuclear Energy Stock Under $10? Barchart - 8 minutes ago
ASP Isotopes is a nuclear energy stock priced under $10 that is positioned to deliver outsized gains to shareholders in the upcoming decade. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot